We experimentally validated the oncogenic role of MBOAT1 in GBM through both in vivo and in vitro experiments.<h4>Results</h4>MBOAT1 expression was elevated in glioma and correlated with increased grades and poor patient prognosis. The gene discussed is MBOAT1; the disease is glioblastoma.